The team demonstrated this both in mouse liver cancer cells and in several human cancer cell lines. The findings are ...

and KEYNOTE-365 which is investigating multiple combinations with other drugs given on top of first-line hormonal therapy. Hepatocellular carcinoma (HCC) – the most common form of liver cancer ...

Based on promising preclinical data, researchers hope to begin clinically testing PLK1-targeted treatments in young people with fibrolamellar carcinoma.

Blocking the activity of the protein turns formerly "cold," or immune-resistant, liver tumors in mice into "hot" tumors teeming with cancer-fighting immune cells. When combined with an ...

Liver cancer kills around 750,000 people a year worldwide with 69,000 of those in Europe. Hepatocellular carcinoma represents approximately 90% of primary liver cancer cases and surgery to remove ...

When they are broken down inside our cells ... stored in liver cells. Likewise, there are certain tumour cells that rely on pyruvate metabolism, such as in some types of prostate cancer.

Bristol Myers Squibb (BMS) has announced that its dual immunotherapy combination has been approved by the US Food and Drug Administration (FDA) to treat patients with hepatocellular carcinoma (HCC), ...